1) Yoshikawa H, Adachi Y, Nakamura Y et al : Nationwide survey of Lambert-Eaton myasthenic syndrome in Japan. BMJ Neurol Open 4 : e000291, 2022
2) Eaton LM, Lambert EH : Electromyography and electric stimulation of nerves in diseases of motor unit ; observations on myasthenic syndrome associated with malignant tumors. JAMA 163 : 1117-1124, 1957
3) Motomura M, Nakata R, Shiraishi H : Lambert-Eaton myasthenic syndrome : Clinical review. Clicnical and Experimental Neuroimmunology 7 : 238-245, 2016
4) 北之園寛子, 白石裕一, 本村政勝 : 【Antibody Update 2018】P/Q型カルシウムチャネル抗体とランバート・イートン筋無力症候群 BRAIN and NERVE 70 : 341-355, 2018
5) 松本理器, 本村政勝, 吉村俊朗 他 : Lambert-Eaton筋無力症候群型の神経筋伝達障害を示した重症筋無力症 血清自己抗体と神経筋接合部生検の有用性. 臨床神経学 39 : 531-537, 1999
6) Matsumoto H, Ohtomo G, Akahori T et al : Lambert-Eaton myasthenic syndrome with anti-acetylcholine receptor antibody and anterior mediastinal tumor. J Gen Fam Med 18 : 282-284, 2017
7) Lorenzoni PJ, Scola RH, Kay CSK et al : How to spot congenital myasthenic syndromes resembling the Lambert-Eaton myasthenic syndrome? A brief review of clinical, electrophysiological, and genetics features. Neuromolecular Med 20 : 205-214, 2018
8) Nakao YK, Motomura M, Fukudome T et al : Seronegative Lambert-Eaton myasthenic syndrome : study of 110 Japanese patients. Neurology 59 : 1773-1775, 2002
9) O'Neill JH, Murray NM, Newsom-Davis J : The Lambert-Eaton myasthenic syndrome. A review of 50 cases. Brain 111 : 577-596, 1988
10) Titulaer MJ, Wirtz PW, Kuks JB et al : The Lambert-Eaton myasthenic syndrome 1988-2008 : a clinical picture in 97 patients. J Neuroimmunol 201-202 : 153-158, 2008
11) Abenroth DC, Smith AG, Greenlee JE et al : Lambert-Eaton myasthenic syndrome : Epidemiology and therapeutic response in the national veterans affairs population. Muscle Nerve 56 : 421-426, 2017
12) Liu Y, Xi J, Zhou L et al : Clinical characteristics and long term follow-up of Lambert-Eaton myasthenia syndrome in patients with and without small cell lung cancer. J Clin Neurosci 65 : 41-45, 2019
13) Morimoto M, Osaki T, Nagara Y et al : Thymoma with Lambert-Eaton myasthenic syndrome. Ann Thorac Surg 89 : 2001-2003, 2010
14) Oyaizu T, Okada Y, Sagawa M Y et al : Lambert-Eaton myasthenic syndrome associated with an anterior mediastinal small cell carcinoma. J Thorac Cardiovasc Surg 121 : 1005-1006, 2001
15) Siau RT, Morris A, Karoo RO : Surgery results in complete cure of Lambert-Eaton myasthenic syndrome in a patient with metastatic Merkel cell carcinoma. J Plast Reconstr Aesthet Surg 67 : e162-e164, 2014
16) Ferlito A, Rinaldo A, Bishop JA et al : Paraneoplastic syndromes in patients with laryngeal neuroendocrine carcinomas : clinical manifestations and prognostic significance. Eur Arch Otorhinolaryngol 273 : 533-536, 2016
17) Nalbantoglu M, Kose L, Uzun N et al : Lambert-Eaton myasthenic syndrome associated with thymic neuroendocrine carcinoma. Muscle Nerve 51 : 936-938, 2015
18) Iyer JG, Parvathaneni K, Bhatia S et al : Paraneoplastic syndromes (PNS) associated with Merkel cell carcinoma (MCC) : A case series of 8 patients highlighting different clinical manifestations. J Am Acad Dermatol 75 : 541-547, 2016
19) Pavolucci L, Giannini G, Giannoccaro MP et al : Paraneoplastic cerebellar degeneration and lambert-eaton myasthenia in a patient with merkel cell carcinoma and voltage-gated calcium channel antibodies. Muscle Nerve 56 : 998-1000, 2017
20) Takasugi J, Shimamura M, Koda T et al : A case of paraneoplastic cerebellar degeneration and Lambert-Eaton myasthenic syndrome associated with neuroendocrine carcinoma of the oropharynx. Intern Med 57 : 587-590, 2017
21) Fukuda T, Motomura M, Nakao Y et al : Reduction of P/Q-type calcium channels in the postmortem cerebellum of paraneoplastic cerebellar degeneration with Lambert-Eaton myasthenic syndrome. Ann Neurol 53 : 21-28, 2003
22) Shimizu F, Takeshita Y, Sano Y et al : GRP78 antibodies damage the blood-brain barrier and relate to cerebellar degeneration in Lambert-Eaton myasthenic syndrome. Brain 142 : 2253-2264, 2019
23) Winklehner M, Bauer J, Endmayr V et al : Paraneoplastic cerebellar degeneration with P/Q-VGCC vs Yo autoantibodies. Neurol Neuroimmunol Neuroinflamm 9 : e200006, 2022
24) Maddison P, Newsom-Davis J, Mills KR : Distribution of electrophysiological abnormality in Lambert-Eaton myasthenic syndrome. J Neurol Neurosurg Psychiatry 65 : 213-217, 1998
25) Oh SJ, Kurokawa K, Claussen GC et al : Electrophysiological diagnostic criteria of Lambert-Eaton myasthenic syndrome. Muscle Nerve 32 : 515-520, 2005
26) Hatanaka Y, Oh SJ : Ten-second exercise is superior to 30-second exercise for post-exercise facilitation in diagnosing Lambert-Eaton myasthenic syndrome. Muscle Nerve 37 : 572-575, 2008
27) Chiou-Tan FY, Gilchrist JM : Repetitive nerve stimulation and single-fiber electromyography in the evaluation of patients with suspected myasthenia gravis or Lambert-Eaton myasthenic syndrome : review of recent literature. Muscle Nerve 52 : 455-462, 2015
28) Motomura M, Johnston I, Lang B et al : An improved diagnostic assay for Lambert-Eaton myasthenic syndrome. J Neurol Neurolosurg Psychiatry 58 : 85-87, 1995
29) Lennon VA, Kryzer TJ, Griesmann GE et al : Calcium-channel antibodies in the Lambert-Eaton syndrome and other paraneoplastic syndromes. N Engl J Med 332 : 1467-1474, 1995
30) Zalewski NL, Lennon VA, Lachance DH et al : P/Q- and N-type calcium-channel antibodies : oncological, neurological, and serological accompaniments. Muscle Nerve 54 : 220-227, 2016
31) Newsom-Davis J : A treatment algorithm for Lambert-Eaton myasthenic syndrome. Ann N Y Acad Sci 841 : 817-822, 1998
32) Maddison P, Newsom-Davis J : Treatment for Lambert-Eaton myasthenic syndrome. THE COCHRANE COLLABORATION, 2008
33) Skeie GO, Apostolski S, Evoli A et al : Guidelines for treatment of autoimmune neuromuscular transmission disorders. Eur J Neurol 17 : 893-902, 2010
34) Yamasaki H, Futamura N, Funakawa I et al : Two Lambert-Eaton myasthenic syndrome patients with ameliorated activities of daily living due to cholinesterase inhibitors. Intern Med 61 : 1063-1065, 2022
35) Maddison P, Gozzard P, Grainge MJ et al : Long-term survival in paraneoplastic Lambert-Eaton myasthenic syndrome. Neurology 88 : 1334-1339, 2017